Coverage
What this agreement covers.
Goods, services and investment where applicable
Key benefits
Why this agreement matters.
- ✓ Switzerland goods enter EU at 0% via bilateral agreements
- ✓ Swiss pharma (Novartis, Roche) has full EU market access — competes with Indian generic pharma
- ✓ New institutional agreement under negotiation to replace bilateral framework
India position
How this FTA relates to India.
Third-party — Switzerland competes with India in EU for pharma and precision engineering
Aggregate trade volume among parties: USD 300B
Beneficiary verticals
Which sectors benefit.
Travelogue Forum
Have a question or insight on EU-Switzerland Bilateral Agreements? Start a thread in Trade Agreements & Policy.
Discuss on the Forum →